baber/WOPTO huggingface dataset:
Patent NZ-545820-A (NZ)
Title: Composition and method for crop protection
Inventor: HUNTER GREGORY S
IPC: C09D7/61
Filed: 2004-08-27
Abstract: Disclosed is a slurry composition for protecting crops, comprising:  a phyllosilicate mineral  a chelating agent; and  multivalent ions wherein the composition has a pH of between about 9.0 and about 11.6. Also disclosed is a horticultural substrate coated with the above composition and a method of protecting a crop from freezing or a method for protecting crops from pest infestation, comprising applying to at least a portion of a surface of a crop an effective amount of the above slurry composition.
Patent NZ-547136-A (NZ)
Title: Oral drip system (medical device)
Inventor: O'CONNELL CAVAN JOHN
Filed: 2006-08-12
Abstract: An oral liquid dispenser is disclosed. The oral liquid dispenser includes a vessel containing a gas and liquid phase, and a pressure equalising tube that extends between the interior gas phase and exterior atmosphere of the vessel. A cap on the vessel seals the vessel and includes an aperture through which liquid may pass. A dispenser is configured to deliver the liquid from the vessel orally to a user via tubing linking the cap on the vessel to the dispenser.
Patent NZ-551416-A (NZ)
Title: Preparation and uses of 6-hydroxy-8-{(R)-1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethylethylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one hydrochloride (Betamimetika)
Inventor: KONETZKI INGO
IPC: A61K31/536
Filed: 2005-05-11
Abstract: Disclosed is the preparation and uses thereof of 6-hydroxy-8-{(R)-1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethylethylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one hydrochloride as an enantiomerically pure compound and represented by the formula I, with an enantiomeric purity of at least 85% enantiomeric excess (ee), optionally in the form of a tautomer, mixture of the tautomers, hydrate or solvate thereof. Also disclosed is the use of an enantiomerically pure compound as defined above for preparing a pharmaceutical composition for the treatment of respiratory complaints.
Patent NZ-555671-A (NZ)
Title: Methods for improved shelf life of liquid bacterium incoculants, including on seed stabilization, by partially desiccating the inoculant
Inventor: PEARCE JEREMY DAVID
IPC: A01N63/27
Filed: 2005-11-14
Abstract: Disclosed is a method for preparing a partially desiccated inoculant product, the method comprising: providing a liquid inoculant of a bacterium grown to a substantially stationary phase; and adding in an amount sufficient to partially desiccate the liquid inoculant, a desiccant treatment comprising a desiccant to the liquid inoculant to form the partially desiccated liquid inoculant product. Also disclosed is a method for treating seeds comprising applying a partially desiccated inoculant product to a seed.
Patent NZ-562341-A (NZ)
Title: Pressure assisted thermal sterilisation or pasteurisation method and apparatus
Inventor: FARID MOHAMMED
Filed: 2006-04-10
Abstract: An apparatus and method for pasteurising or sterilising a liquid, semi-liquid, or solid article is disclosed. The method comprises the step of heating the liquid, semi-liquid, or solid article and/or an associated medium within a confined volume, in the absence of a gaseous phase within the confined volume, sufficiently that expansion of the article and/or of the medium subjects the article to a pressure sufficient, when combined with the heating to pasteurise or sterilise the article. The heating is to a temperature which is less than that required to pasteurise or sterilise the article in the absence of the pressure and/or being for a duration of exposure of the article to the heating less than that required to pasteurise or sterilise the article in the absence of the pressure.
Patent NZ-564307-A (NZ)
Title: Improved antimicrobial peroxidase compositions
Inventor: VAN DEN PLAS DAVE
IPC: A61L26/00
Filed: 2006-06-13
Abstract: Disclosed is a pharmaceutical composition comprising a combination of a peroxide or a peroxide generating system, one or more peroxidases, and one or more enhancing agents, wherein the enhancing agent is a benzene molecule, substituted with -OH or (CH2)nOH, where n is 1, 2, 3 or 4, and also substituted with one alkoxy group with a chain length of 1, 2, 3 or 4 carbon atoms, and further optionally substituted with 1 to 4 substituents, each independently selected from a hydroxy group, an aldehyde, a ketone, an acid and a halogen, an hydroxyalkyl group with 1, 2, 3 or 4 carbon atoms, a linear or branched alkyl group or a linear or branched alkenyl group with 1, 2, 3 or 4 carbon atoms, wherein said hydroxyalkyl, alkyl or alkenyl groups are further optionally substituted with a halogen, carboxyl, hydroxyl, aldehyde or ketone group. Also disclosed is the use of this composition for treating skin disorders such as healing wounds.
Patent NZ-565150-A (NZ)
Title: Pyrazine derivatives useful as adenosine receptor antagonists
Inventor: VIDAL JUAN BERNAT
IPC: A61K31/497
Filed: 2006-07-25
Abstract: Disclosed is a secondary pyrazine amine of formula (I) wherein: A represents an aryl or heteroaryl group, B represents a nitrogen-containing heteroaryl group and R1 and R2 are defined in the specification and the pharmaceutically acceptable salts and N-oxides thereof. Also disclosed is a composition comprising said amine and the use of said amine in the treatment of a condition susceptible of being improved by antagonism with the A2B adenosine receptor for example, hypertension and inflammation.
Patent NZ-565797-A (NZ)
Title: Capturing wave energy from rotational and vertical motion
Inventor: FARB DANIEL
IPC: F03B13/12
Filed: 2007-01-02
Abstract: Disclosed is an energy capture system for extracting mechanical energy from wave motion of a body of water. The system includes a flotation device comprised of a paddle wheel (32) or propeller connected to a rotatable rod (33), a vertical support shaft and a linkage arrangement. Mechanical energy can be extracted from the body of water by submerging the paddle wheel (32) or propeller at least partially in the water such that the paddle wheel (32) or propeller is caused to rotate and impart rotational mechanical energy to the rotatable rod (33). Mechanical energy can also be extracted from the wave motion by the flotation device ascending and descending the vertical support shaft, to which it is slidingly connected, with the wave motion of the body of water. This mechanical energy is transformed into a harnessable form by the linkage arrangement connected to the flotation device.
Patent NZ-568584-A (NZ)
Title: Handrail bracket with the bracket arm and wall connection are separate but connectable by a rotational interlock
Inventor: PIZZEY JOHN ELLIOTT
IPC: F16B1/00
Filed: 2006-11-29
Abstract: A handrail bracket is disclosed. The bracket is designed to enable fasteners that join the bracket to the wall to be selectively placed rather than having their locations determined by the angle of the handrail. The bracket has two major parts, a bracket arm (10) and a mounting element (27). The bracket arm (10) has means (21) for supporting a handrail at one end and a mounting foot (19) at the other. The mounting element (27) is adapted to be fixed to a support and includes an opening (36). The mounting foot (19) has a projecting portion (26) with at least two opposed shoulders (23) which are received by the opening (36). Cooperating retaining shoulders (38) on the mounting means (27) are engaged by the shoulders (23) on the mounting foot (19) by rotational movement of the mounting foot (19) within the mounting element (27), locking the foot (19) to the element (27). In use this means that the orientation of the mounting element (27) can be chosen so that fasteners passing through holes (31) in the mounting element (27) are able to be screwed into something solid and then the arm (10) can be rotated to the correct angle for the handrail.
Patent NZ-575125-A (NZ)
Title: Method for preparing 5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole and its salts
Inventor: REINE INESE
IPC: C07D233/54
Filed: 2007-11-02
Abstract: Disclosed is a process for preparation (±)-5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole hydrochloride of formula (VIII), which comprises the steps of: a) reacting of the 4-imidazole derivative of formula (I) wherein R1 is halogen, and R2 is a trityl group, with 2,3-dimethylbenzaldehyde to obtain compound of formula (III), b) oxidation of the compound of formula (III) to obtain compound of formula (IV); c) reaction of the compound of formula (IV) with Gringard reagent R3MgHal, wherein R3 is alkyl and Hal is halogen, to obtain compound of formula (V), d) removing the group R2 from the compound of formula (V), by treatment with an acid, to obtain the compound of formula (VI), e) hydrogenation the compound of formula (VI) to obtain compound of formula (VII), and f) crystallization the compound of formula (VII) to obtain the compound of formula (VIII).
Patent NZ-578366-A (NZ)
Title: Gutter mounting assembly including u-shaped support and spacers to provide overflow gap
Inventor: HIGGINS IAN JOHN
IPC: E04D13/064
Filed: 2008-01-11
Abstract: A mounting assembly for a channel shaped gutter. The mounting assembly (210) incudes: a support assembly (220) to support the gutter on an upright surface (300) of a building and a plurality of spacers (230) disposed at spaced intervals along the support assembly. The support assembly has a U-shape in end profile with two legs, with a space defined between the legs of the U-shaped support assembly defining a recess (240) into which an in-use internal wall of the channel-shaped gutter can be received for mounting the gutter to the building. Projections are defined on one leg of the U -shaped support assembly which extend into the recess and are adapted to engage an elongate ridge defined along the gutter internal wall when it is received in the recess, thereby retaining the gutter internal wall in the recess of the U-shaped support assembly. The spacers are arranged to locate between the in-use inner side of the gutter and the upright surface to provide an overflow gap between the upright surface and the gutter.
Patent NZ-579537-A (NZ)
Title: A method for the prevention of thromboembolic disorders
Inventor: HAIKALA HEIMO
IPC: A61K31/50
Filed: 2005-05-12
Abstract: Disclosed is the use of levosimendan or (R)-N-[4-(1, 4, 5, 6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]acetamide or any of their pharmaceutically acceptable salts in the manufacture of a medicament for the prevention of thrombotic or embolic peripheral circulatory disorder or deep vein thrombosis. (62) Divided Out of 550814
Patent NZ-579676-A (NZ)
Title: Modulation of stem and progenitor cell differentiation, assays, and uses thereof
Inventor: HARIRI ROBERT J
IPC: C12N5/0784
Filed: 2003-04-13
Abstract: Disclosed is the use of a composition in the preparation of a medicament for the treatment of a condition treatable with granulocytes in an individual, said condition selected from neutropenia, chronic granulomatous disease and an infection, wherein said composition comprises a therapeutically effective amount of white blood cells comprising granulocyte precursors, wherein said white blood cells are generated by a method comprising contacting mammalian CD34+ or CD133+ hematopoietic stem cells in vitro with an amino-substituted thalidomide analog under conditions under which said stem cells differentiate, wherein the amino-substituted thalidomide analog is 4( amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1 ,3-dione or 3-(4-amino-1-oxo-1 ,3-dihydroisoindo1-2-yl)-piperidine-2,6-dione.
Patent NZ-583017-A (NZ)
Title: Methods of preparing 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds
Inventor: ZHANG HAIMING
IPC: A61K31/506
Filed: 2008-08-22
Abstract: Disclosed are methods of preparing trifluoro-phenylethoxy compounds, represented by general formula II(a), by contacting a compound of general formula (IV) with a platinum group metal catalyst having a chiral ligand. Examples of the compounds of general formula (IV) include 1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl-2,2,2-trifluoroethanone and 1-(2-bromo-5-chlorophenyl)-3-methyl-1H-pyrazole.
Patent NZ-584239-A (NZ)
Title: Appratus for positioning a teat cup on a rotatable platform using automated means
Inventor: DANNEKER GERT
IPC: A01J5/017
Filed: 2008-11-17
Abstract: Disclosed is an apparatus which includes a rotatable platform, a milking stall provided on the platform, and means for controlling movement of a teat cup magazine relative to the stall. The controlling means provides the teat cup magazine with a first predefined position relative to a milking stall and a second predefined position relative to the milking stall, and comprises automated means for moving the teat cup magazine between the first and second predefined positions. The position of the teat cup magazine, relative to the stall, is dependent upon the position of the stall within its rotary cycle.
Patent NZ-591901-A (NZ)
Title: An abrasive fluoride dentifrice composition comprising xanthan, carbomer, carageenan and thickening silica
Inventor: CRAWSHAW ANDREW GORDON
IPC: A61K8/25
Filed: 2009-09-28
Abstract: Disclosed is a dentifrice composition comprising a source of fluoride ions and a xanthan gum, a carbomer a carageenan gum, a thickening silica and a silica dental abrasive and wherein the composition has a pH of between 5.5 and 6.5.
Patent NZ-592544-A (NZ)
Title: Isonicotinamide orexin receptor antagonists
Inventor: BERGMAN JEFFREY M
IPC: C07D401/12
Filed: 2009-10-26
Abstract: 592544 Disclosed are isonicotinamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. Also disclosed are pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved. Examples of the compounds are: N-(3,4-dimethoxybenzyl)-2,5-bis(3,5-dimethylphenyl) isonicotinamide; N -(3 ,4-dimethoxybenzyl)-6-(3 ,5-dimethylphenyl)-3,3  -bipyridine-4-carboxamide and N-(3,4-dimethoxybenzyl)-2-(3,5-dimethylphenyl)-5-(1-methy1-1H-pyrazol-4-yl)isonicotinamide.
Patent NZ-593385-A (NZ)
Title: Single recombination system and methods of use
Inventor: LEYRER SONJA
IPC: C12N15/863
Filed: 2009-12-16
Abstract: Disclosed is a modified poxvirus vector that allows for the generation of recombinant poxviruses by a single recombination event. A modified poxvirus vector comprising at least one reporter gene located between two flanking sequences for homologous recombination and a selection gene whose expression is regulated by the tetracycline operator/repressor system. Furthermore, a host cell comprising said vector and a method for the generation of recombinant poxviruses using said vector are provided.
Patent NZ-593507-A (NZ)
Title: A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus
Inventor: CALAFIORE RICCARDO
IPC: A61P3/10
Filed: 2009-12-18
Abstract: Disclosed is a process for the manufacture of hydrogel-based microcapsules, containing Sertoli cells (SC), comprising the following steps: Production of a homogeneous suspension of SC with purity, in terms of cell composition, higher than 90%, in a saline solution of ultrapure sodium alginate with a concentration ranging from 1 to 5 percent w/x; Aspiration of said suspension at a speed between 10 and 60 m/minute and introduction into a needle-type element; regulation of pressure in the needle-type element; Extrusion of said suspension inside said needle  type element through emission of a fluid stream of 3-7 litre/min thereby obtaining a continuous flow of microdroplets showing homogenous dimensions; Introduction of said microdroplets of said flow into an aqueous solution containing divalent cations or polycationic substances with resulting gelification and obtainment of said microcapsules. Futher disclosed is the use of said preparation a sole therapeutic agent in the manufacture of a medicament for prevention and treatment of Type-1 Diabetes Mellitus.
Patent NZ-597239-A (NZ)
Title: Pharmaceutical composition for emergency contraception
Inventor: LINDENTHAL BERNHARD
IPC: A61K31/18
Filed: 2010-06-10
Abstract: 597239 Disclosed herein is a pharmaceutical composition to be administered in a single dose, characterized in that it contains: 50-900 ?g levonorgestrel, 1-30 mg dienogest, 60-900 ?g desogestrel, 30-750 ?g gestodene, 1.5-75 mg chlormadinone acetate (CMA), 180-3700 ?g norgestimate (NGM), 1-15 mg cyproterone acetate (CPA), 2-30 mg drospirenone (DRSP), 30-450 mgdydrogesterone, 2-30 mg ethynodiol, 2-30 mg lynestrenol, 10-150 mg medrogestone, 10-150 mg medroxyprogesterone acetate (MPA), 0.5-8 mg norethisterone, 0.5-8 mg norethisterone acetate (NETA), 300-4500 mg progesterone, 0.5-8 mg promegestone, 0.5-8 mg trimegestone or 2.5-37 mg nomegestrol acetate (NOMAc) and as COX inhibitors 5-60 mg piroxicam, 300-3800 mg naproxen, 100-1200 mg celecoxib, 50-600 mg indomethacin, 40-450 mg diclofenac, 50-600 mg nimesulide, 4-48 mg lornoxicam or 10-120 mg tenoxicam as active substances, and the known auxiliaries used in pharmaceutical practice, and the use thereof as an emergency contraceptive.
Patent NZ-598087-A (NZ)
Title: Bracket fixing for a safety line
Inventor: JONES OWAIN
IPC: A62B35/04
Filed: 2010-09-01
Abstract: 598087 Disclosed is a safety line bracket fixing for a fall arrest system where the safety line is horizontal such as when used when working on roofs. The bracket fixing for securing a safety line to a structure includes a safety line receiving portion, and a fixing portion connected to the safety line receiving portion. The fixing portion having a captive mechanical fixing, arranged to engage with and secure the bracket to the structure. The captive mechanical fixing includes a bolt and the fixing portion is formed about the head of the bolt to hold the bolt head captive. The safety line receiving portion includes an elongate tube portion for receiving the safety line. The fixing portion is spaced from the tube portion in a direction transverse to the elongate tube portion.
Patent NZ-599820-A (NZ)
Title: Method for controlling the carbon and/or oxygen content of a powder injection moulded product
Inventor: HAMILTON HUGH GAVIN CHARLES
IPC: B22F3/22
Filed: 2010-10-13
Abstract: A method for controlling the carbon and/or oxygen content in a material suitable for powder metallurgical applications is disclosed, wherein the method comprises the steps of: (a) forming a feedstock composition comprising at least one powder, at least one platinum group metal selected from the group consisting of at least one of platinum, palladium, rhodium, ruthenium, iridium and osmium and at least one binder such as stearic acid, glycerine, polymethylmethacrylate, paraffin wax or carnauba wax (a particularly preferred binder is the binder developed by Egide UK); and (b) forming the material by powder injection molding; wherein at least a proportion of the carbon and/or oxygen is catalytically removed by the at least one platinum group metal.
Patent NZ-601040-A (NZ)
Title: Method of producing acrylic and methacrylic acid
Inventor: POLIAKOFF MARTYN
IPC: C07C51/38
Filed: 2010-12-21
Abstract: Disclosed herein is a method of producing a compound of formula (i): wherein the method comprising exposing a compound of formula (ii) to reaction conditions of temperature and pressure while being in a liquid phase, optionally, an aqueous phase, wherein R = H or CH3, wherein when R = CH3, the compound of formula (ii) is exposed to reaction conditions of a temperature of at least 100°C and less than 425°C and a pressure in excess of atmospheric pressure and less than 10,000 psi. Particularly disclosed is the process of producing methacrylic acid or acrylic acid by the decomposition of citramalic acid or malic acid respectively, in the presence of a catalyst such as sodium hydroxide, at elevated temperature and pressure conditions.
Patent NZ-601728-A (NZ)
Title: Fuel cartridge
Inventor: RICORDI CHRISTIAN
IPC: B25C1/18
Filed: 2011-02-22
Abstract: The cartridge (1) contains fuel in a liquid phase (8) and in a vapour phase (9) with an additive (10) in the vapour phase and a small amount of additive (11) also dissolved in the liquid phase (8). the additive is either hydrogen or acetylene. The fuel mixture in the cartridge has an explosivity in the range of approximately 2.5% to approximately 81%. The power of the fastening tools operating with such a cartridge can be lowered over comparable fuels.
Patent NZ-602191-A (NZ)
Title: Heterocyclic amides as rock inhibitors
Inventor: LEYSEN DIRK
IPC: C07D493/04
Filed: 2011-03-04
Abstract: The present disclosure relates to new kinase inhibitors of formula (I), more specifically ROCK (Rho-associated protein kinase) inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In particular, the present disclosure relates to new ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the disclosure relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including sexual dysfunction, inflammatory diseases, ophthalmic diseases and Respiratory diseases. Compounds disclosed include: ({ 5-[2-Aminomethyl-5-(pyridin-4-ylcarbamoyl)-phenyl]-thiophene-2- carbonyl} -amino)-acetic acid methyl ester { 2-[2’-Aminomethyl-5’-(pyridin-4-ylcarbamoyl)-biphenyl-3-yloxy]-acetylamino} -acetic acid methyl ester [2’-Aminomethyl-5’-(pyridin-4- ylcarbamoyl)-biphenyl-4-yloxy]- thioacetic acid S-fluoromethyl ester [2’-(1-Amino-ethyl)-5’-(3-fluoro- pyridin-4-ylcarbamoyl)-biphenyl-3-yloxy]-acetic acid propyl ester 6-Aminomethyl-3’-[2-(2-oxo- tetrahydro-furan-3-yloxy)- ethylamino]-biphenyl-3-carboxylic acid pyridin-4-ylamide 6-(1-Amino-ethyl)-3’-[3-(2-oxo- tetrahydro-furan-3-ylsulfanyl)- propoxy]-biphenyl-3-carboxylylic acid pyridin-4-ylamide 2’-(1-Amino-ethyl)-5’-(pyridin-4- ylcarbamoyl)-biphenyl-3-carboxylic acid cyclopropylmethyl ester And 2’-Aminomethyl-5’-(pyridin-4- ylcarbamoyl)-biphenyl-3-carboxylic acid methyl ester
Patent NZ-609752-A (NZ)
Title: Process for preparing maytansinoid antibody conjugates
Inventor: AMPHLETT GODFREY W
IPC: A61K47/48
Filed: 2006-08-14
Abstract: Disclosed is a process for preparing an antibody-cytotoxic agent conjugate comprising the steps of: (a) contacting an antibody with a bifunctional crosslinking reagent to covalently attach a linker to the antibody and thereby prepare a first mixture comprising antibodies having linkers bound thereto, (b) subjecting the first mixture to adsorptive chromatography and thereby prepare a purified first mixture of antibodies having linkers bound thereto, (c) conjugating a cytotoxic agent to the antibodies having linkers bound thereto in the purified first mixture by reacting the antibodies having linkers bound thereto with a cytotoxic agent in a solution having a pH of about 4 to about 9 to prepare a second mixture comprising (i) antibody chemically coupled through the linker to the cytotoxic agent, (ii) free cytotoxic agent, and (iii) reaction by-products, and (d) subjecting the second mixture to adsorptive chromatography to purify the antibodies chemically coupled through the linkers to the cytotoxic agent from the other components of the second mixture and thereby prepare a purified second mixture of antibodies chemically coupled through the linkers to the cytotoxic agent.